Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymorphisms of the <i>FCN2</i> Gene 3'UTR Region and Their Clinical Associations in Preterm Newborns.

Frontiers in immunology·2021
Same author

Components of the lectin pathway of complement activation in paediatric patients of intensive care units.

Immunobiology·2016
Same author

No Strong Relationship Between Components of the Lectin Pathway of Complement and Susceptibility to Pulmonary Tuberculosis.

Inflammation·2015
Same author

Lack of association of serum mannose/mannan binding lectin or ficolins with complement activation in patients with antiphospholipid antibodies.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2014
Same author

Serum ficolin-2 in hospitalised patients with community-acquired pneumonia.

Inflammation·2014
Same author

Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study.

The Lancet. Respiratory medicine·2014

Related Experiment Video

Updated: Jul 5, 2026

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Stem cell transplantation and MBL replacement therapy.

David C Kilpatrick1

  • 1Scottish National Blood Transfusion Service, Ellen's Glen Road, Edinburgh, EH 17 7QT, Scotland, UK. dave.kilpatrick@snbts.csa.scot.nhs.uk

Current Stem Cell Research & Therapy
|May 14, 2008
PubMed
Summary

Mannose-binding lectin (MBL) may affect infection risk in patients undergoing chemotherapy or stem cell transplants. Donor MBL-2 gene mutations surprisingly influenced recipient infection risk, suggesting novel immune mechanisms.

More Related Videos

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jul 5, 2026

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Area of Science:

  • Immunology
  • Hematology
  • Genetics

Background:

  • Mannose-binding lectin (MBL) plays a role in innate immunity.
  • MBL influences infection susceptibility in patients undergoing chemotherapy and stem cell transplantation.
  • Previous research on MBL's role in these patient groups has yielded inconsistent findings.

Purpose of the Study:

  • To investigate the influence of MBL on infection susceptibility in patients receiving chemotherapy or stem cell transplants.
  • To explore the surprising observation that donor MBL-2 gene mutations affect recipient infection risk.
  • To discuss potential mechanisms, including MBL binding to autologous cells, and its implications for MBL replacement therapy.

Main Methods:

  • Review of existing literature on MBL, chemotherapy, stem cell transplantation, and infection risk.
  • Analysis of studies reporting MBL-2 gene mutations in donors and their impact on allogeneic stem cell transplant recipients.
  • Evaluation of evidence regarding MBL synthesis by leukocytes and MBL-cell interactions.

Main Results:

  • MBL may influence infection susceptibility in patients undergoing chemotherapy or stem cell transplantation.
  • Donor MBL-2 gene mutations were found to influence the risk of serious infections in allogeneic stem cell transplant recipients.
  • Evidence suggests MBL may bind to autologous cells, potentially inducing immunological maturation.

Conclusions:

  • Donor MBL-2 genotype is a significant factor influencing infection risk in stem cell transplant recipients.
  • The mechanism likely involves MBL binding to host cells rather than MBL production by donor leukocytes.
  • Understanding MBL-cell interactions is crucial for developing MBL replacement therapies.